97 related articles for article (PubMed ID: 1561525)
1. Decreased in vitro production of tumor necrosis factor in primary biliary cirrhosis patients.
Broomé U; Eriksson LS; Sundin U; Sundqvist KG
Scand J Gastroenterol; 1992; 27(2):124-8. PubMed ID: 1561525
[TBL] [Abstract][Full Text] [Related]
2. Tumour necrosis factor alpha impairs function of liver derived T lymphocytes and natural killer cells in patients with primary sclerosing cholangitis.
Bo X; Broome U; Remberger M; Sumitran-Holgersson S
Gut; 2001 Jul; 49(1):131-41. PubMed ID: 11413121
[TBL] [Abstract][Full Text] [Related]
3. Altered biliary epithelial cell and monocyte responses to lipopolysaccharide as a TLR ligand in patients with primary biliary cirrhosis.
Zhao J; Zhao S; Zhou G; Liang L; Guo X; Mao P; Zhou X; Wang H; Nan Y; Xu D; Yu J
Scand J Gastroenterol; 2011 Apr; 46(4):485-94. PubMed ID: 21275501
[TBL] [Abstract][Full Text] [Related]
4. Production of tumor necrosis factor, interleukin 1, and interferon-gamma by peripheral blood mononuclear cells from patients with primary biliary cirrhosis.
Kakumu S; Yoshioka K; Tsutsumi Y; Wakita T; Arao M
Clin Immunol Immunopathol; 1990 Jul; 56(1):54-65. PubMed ID: 2113448
[TBL] [Abstract][Full Text] [Related]
5. Adhesion molecule expression in primary sclerosing cholangitis and primary biliary cirrhosis.
Bloom S; Fleming K; Chapman R
Gut; 1995 Apr; 36(4):604-9. PubMed ID: 7537707
[TBL] [Abstract][Full Text] [Related]
6. Decreased Expression of Vitamin D Receptor Affects an Immune Response in Primary Biliary Cholangitis via the VDR-miRNA155-SOCS1 Pathway.
Kempinska-Podhorodecka A; Milkiewicz M; Wasik U; Ligocka J; Zawadzki M; Krawczyk M; Milkiewicz P
Int J Mol Sci; 2017 Jan; 18(2):. PubMed ID: 28146070
[TBL] [Abstract][Full Text] [Related]
7. Liver Expression of Sulphotransferase 2A1 Enzyme Is Impaired in Patients with Primary Sclerosing Cholangitis: Lack of the Response to Enhanced Expression of PXR.
Wunsch E; Klak M; Wasik U; Milkiewicz M; Blatkiewicz M; Urasinska E; Barbier O; Bielicki D; Bogdanos DP; Elias E; Milkiewicz P
J Immunol Res; 2015; 2015():571353. PubMed ID: 26504856
[TBL] [Abstract][Full Text] [Related]
8. Hepatic copper content is normal in early primary biliary cirrhosis and primary sclerosing cholangitis.
Kowdley KV; Knox TA; Kaplan MM
Dig Dis Sci; 1994 Nov; 39(11):2416-20. PubMed ID: 7956610
[TBL] [Abstract][Full Text] [Related]
9. Hepatic Stem/Progenitor Cell Activation Differs between Primary Sclerosing and Primary Biliary Cholangitis.
Carpino G; Cardinale V; Folseraas T; Overi D; Floreani A; Franchitto A; Onori P; Cazzagon N; Berloco PB; Karlsen TH; Alvaro D; Gaudio E
Am J Pathol; 2018 Mar; 188(3):627-639. PubMed ID: 29248458
[TBL] [Abstract][Full Text] [Related]
10. Alterations in tight junctions differ between primary biliary cirrhosis and primary sclerosing cholangitis.
Sakisaka S; Kawaguchi T; Taniguchi E; Hanada S; Sasatomi K; Koga H; Harada M; Kimura R; Sata M; Sawada N; Mori M; Todo S; Kurohiji T
Hepatology; 2001 Jun; 33(6):1460-8. PubMed ID: 11391535
[TBL] [Abstract][Full Text] [Related]
11. Reduced coffee consumption among individuals with primary sclerosing cholangitis but not primary biliary cirrhosis.
Lammert C; Juran BD; Schlicht E; Xie X; Atkinson EJ; de Andrade M; Lazaridis KN
Clin Gastroenterol Hepatol; 2014 Sep; 12(9):1562-8. PubMed ID: 24440215
[TBL] [Abstract][Full Text] [Related]
12. Impact of Microbes on the Pathogenesis of Primary Biliary Cirrhosis (PBC) and Primary Sclerosing Cholangitis (PSC).
Mattner J
Int J Mol Sci; 2016 Nov; 17(11):. PubMed ID: 27834858
[TBL] [Abstract][Full Text] [Related]
13. A pilot study exploring the role of glucocorticoid receptor variants in primary biliary cirrhosis and primary sclerosing cholangitis.
ter Borg PC; Hagendorf A; van Buuren HR; Koper JW; Lamberts SW
Neth J Med; 2004 Oct; 62(9):326-31. PubMed ID: 15635817
[TBL] [Abstract][Full Text] [Related]
14. Immunolocalization of putative human liver progenitor cells in livers from patients with end-stage primary biliary cirrhosis and sclerosing cholangitis using the monoclonal antibody OV-6.
Crosby HA; Hubscher S; Fabris L; Joplin R; Sell S; Kelly D; Strain AJ
Am J Pathol; 1998 Mar; 152(3):771-9. PubMed ID: 9502419
[TBL] [Abstract][Full Text] [Related]
15. Autoreactivity to hepatocellular antigens in primary biliary cirrhosis and primary sclerosing cholangitis.
Bedlow AJ; Donaldson PT; McFarlane BM; Lombard M; McFarlane IG; Williams R
J Clin Lab Immunol; 1989 Nov; 30(3):103-9. PubMed ID: 2642168
[TBL] [Abstract][Full Text] [Related]
16. Synthesis of interleukin-1 beta in primary biliary cirrhosis: relationship to treatment with methotrexate or colchicine and disease progression.
Miller LC; Sharma A; McKusick AF; Tassoni JP; Dinarello CA; Kaplan MM
Hepatology; 1995 Aug; 22(2):518-24. PubMed ID: 7635420
[TBL] [Abstract][Full Text] [Related]
17. Surgical treatment of primary biliary cirrhosis and primary sclerosing cholangitis.
Loehe F; Schauer RJ
Clin Rev Allergy Immunol; 2005 Apr; 28(2):167-74. PubMed ID: 15879622
[TBL] [Abstract][Full Text] [Related]
18. Activation of FoxO3a/Bim axis in patients with Primary Biliary Cirrhosis.
Kopycinska J; Kempińska-Podhorodecka A; Haas T; Elias E; DePinho RA; Paik J; Milkiewicz P; Milkiewicz M
Liver Int; 2013 Feb; 33(2):231-8. PubMed ID: 23295054
[TBL] [Abstract][Full Text] [Related]
19. Autoimmune hepatitis type 1 and primary biliary cirrhosis have distinct bone marrow cytokine production.
Zachou K; Rigopoulou EI; Tsikrikoni A; Alexandrakis MG; Passam F; Kyriakou DS; Stathakis NE; Dalekos GN
J Autoimmun; 2005 Dec; 25(4):283-8. PubMed ID: 16242912
[TBL] [Abstract][Full Text] [Related]
20. Immunohistochemical characterization of hepatic lymphocytes in primary biliary cirrhosis in comparison with primary sclerosing cholangitis and autoimmune chronic active hepatitis.
Hashimoto E; Lindor KD; Homburger HA; Dickson ER; Czaja AJ; Wiesner RH; Ludwig J
Mayo Clin Proc; 1993 Nov; 68(11):1049-55. PubMed ID: 8231268
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
